Tibor Kovacsovics, M.D., joined City of Hope in 2023. In his role as a hematologic oncologist and Medical Direct of Leukemia at City of Hope Phoenix, he works with a multidisciplinary team of providers dedicated to diagnosing and managing hematologic malignancies and other blood disorders. Dr. Kovacsovics has extensive expertise in the clinical management of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and amyloidosis, as well as in hematopoietic stem cell transplantation. He brings with him 20 years of experience conducting clinical research on a variety of hematologic malignancies, serving as principal investigator and co-investigator on dozens of groundbreaking studies.
Dr. Kovacsovics earned his medical degree from the University of Geneva School of Medicine, followed by a research fellowship at the University of Lausanne Institute of Biochemistry. After his residency in internal medicine at Clinique Médicale Thérapeutique at Geneva University Hospital, where he served as Chief Resident. Dr. Kovacsovics moved to the United States for his hematology-oncology fellowship at Harvard Medical School/Brigham and Women’s Hospital/Massachusetts General Hospital in Boston, Massachusetts.
He comes to City of Hope after ten years at the University of Utah/Huntsman Cancer Institute, where he served as the Medical Director of the Inpatient Hematologic Malignancies/Transplant Unit, Co-Director of the Acute Leukemia Program in the Division of Hematology and Hematologic Malignancies and Associate Director of the Clinical Trial Group for Hematological Malignancies. Dr. Kovacsovics was also the co-founder of the Utah Amyloidosis Program at the University of Utah/Huntsman. Dr. Kovacsovics is a member of the American Society of Clinical Oncology, American Society of Hematology and International Society of Amyloidosis
